BiotechTube
Home/BenevolentAI/Dr. Anne Phelan
DA

Dr. Anne Phelan

Chief Scientific Officer

BenevolentAI

Therapeutic Areas

ImmunologyNeurologyInflammatory Diseases

BenevolentAI Pipeline

DrugIndicationPhase
BEN-2293 / AZD3470Atopic DermatitisPhase 2a
BEN-8744Ulcerative ColitisPhase 1b
Internal ProgramAmyotrophic Lateral Sclerosis (ALS)Preclinical

Leadership Team at BenevolentAI

JS
Joanna Shields, OBE
Chief Executive Officer
DM
Dr. Michael Branney
Chief Technology Officer
B(
Baroness (Lola) Young of Hornsey, OBE
Independent Non-Executive Director
View full BenevolentAI profile